(Q37086124)

18 August 2017

1 reference

title

Parkinson's disease: genetic versus toxin-induced rodent models (English)

1 reference

18 August 2017

1 reference

2

1 reference

18 August 2017

Mügen Terzioglu

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

12 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

275

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

1384-1391

1 reference

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Toxin-induced models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Evaluation of animal models of Parkinson's disease for neuroprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Animal models of neurological deficits: how relevant is the rat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Parkinson's disease: levodopa-induced dyskinesia and signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

The role of alpha-synuclein in Parkinson's disease: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Genetic mouse models of parkinsonism: strengths and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Parkinson's disease: a rethink of rodent models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Modeling neurodegenerative diseases in vivo review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Detrimental deletions: mitochondria, aging and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Pitx3 is required for development of substantia nigra dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Targeted gene expression in dopamine and serotonin neurons of the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Mitochondrial transcription factor A regulates mtDNA copy number in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

Analysis of dopamine transporter gene expression pattern − generation of DAT-iCre transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06302.X

10.1111/J.1742-4658.2008.06302.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference